Although the natural behavior of MCT does not involve bone tissue, it is possible to attribute the aggressiveness of the disease to the low therapeutic response to RANK-L expression, which helps tumor cells go unrecognized by the host’s immune system. Here, TNFSF11 is linked to neoplasm.